{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:52:55Z","timestamp":1791553975648,"version":"4.3.4"},"reference-count":29,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Molecular stratification has improved drug development, yet treatment effects remain heterogeneous within apparently similar patients. We propose that selected lived exposures be studied as bio-biographical response states: prospectively measured combinations of experience, candidate mediator biology, and treatment context that may modify efficacy, toxicity, adherence, or end point ascertainment. This Perspective translates the concept into a falsifiable development framework. It defines pathway-specific hypotheses, consolidates trial-feasible measures, uses immuno-oncology as an implementation test case, and specifies stage-appropriate evidentiary gates. The framework does not treat adversity as destiny or assume that association establishes causation. It requires reliable measurement, formal interaction estimates, competing-explanation analyses, independent replication, and a defined decision consequence. Used with these guardrails, biography can complement molecular pharmacology by revealing reproducible host states that otherwise appear as unexplained response heterogeneity.<\/jats:p>","DOI":"10.1021\/acsptsci.6c00432","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:01:19Z","timestamp":1789052479000},"page":"2660-2665","source":"Crossref","is-referenced-by-count":0,"title":["Biography as Biology\nin Drug Development: Bio-Biographical\nResponse States for Translational Pharmacology"],"prefix":"10.1021","volume":"9","author":[{"given":"James B.","family":"Baker","sequence":"first","affiliation":[{"name":"Clinica AI , , ,","place":["New York City, New York, United States, 10014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Ghatak","sequence":"additional","affiliation":[{"name":"Clinica AI , , ,","place":["New York City, New York, United States, 10014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Cullen","sequence":"additional","affiliation":[{"name":"Stanford University (retired) , , ,","place":["Palo Alto, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph I.","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Temple University , , ,","place":["Philadelphia, Pennsylvania, United States, 19122"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026100909104760200_cit1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.amjmed.2018.01.019","article-title":"Social Determinants\nof Treatment Response","volume":"131","author":"Bachur","year":"2018","journal-title":"Am. J. Med."},{"key":"2026100909104760200_cit2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat7027","article-title":"Biology, Biography,\nand the Translational Gap","volume":"11","author":"Summers-Trio","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"2026100909104760200_cit3","doi-asserted-by":"publisher","first-page":"100863","DOI":"10.1016\/j.ssmph.2021.100863","article-title":"Biosocial\nMedicine: Biology, Biography, and the Tailored\nCare of the Patient","volume":"15","author":"Horwitz","year":"2021","journal-title":"SSM Popul. Health"},{"key":"2026100909104760200_cit4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s43856-025-01218-6","article-title":"The Imperative of the\nPerson in Personalized Medicine","volume":"5","author":"Horwitz","year":"2025","journal-title":"Commun. Med."},{"key":"2026100909104760200_cit5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory Markers\nin Post-Traumatic Stress Disorder: A Systematic Review, Meta-Analysis,\nand Meta-Regression","volume":"2","author":"Passos","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"2026100909104760200_cit6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41398-022-02094-7","article-title":"The Role of the Immune System in\nPosttraumatic Stress\nDisorder","volume":"12","author":"Katrinli","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"2026100909104760200_cit7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neubiorev.2020.02.002","article-title":"The Association\nbetween Loneliness, Social Isolation and Inflammation: A Systematic\nReview and Meta-Analysis","volume":"112","author":"Smith","year":"2020","journal-title":"Neurosci. Biobehav.\nRev."},{"key":"2026100909104760200_cit8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2023.11.022","article-title":"Social\nIsolation, Loneliness, and Inflammation: A Multi-Cohort Investigation\nin Early and Mid-Adulthood","volume":"115","author":"Matthews","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"2026100909104760200_cit9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000156468","article-title":"Immune\nDysregulation and Chronic\nStress among Older Adults: A Review","volume":"15","author":"Gouin","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"2026100909104760200_cit10","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-024-02929-4","article-title":"Association\nbetween Pretreatment Emotional Distress and Immune Checkpoint Inhibitor\nResponse in Non-Small-Cell Lung Cancer","volume":"30","author":"Zeng","year":"2024","journal-title":"Nat.\nMed."},{"key":"2026100909104760200_cit11","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1038\/s41591-023-02631-x","article-title":"Association between\nPretreatment Emotional Distress and Neoadjuvant Immune Checkpoint\nBlockade Response in Melanoma","volume":"29","author":"Fraterman","year":"2023","journal-title":"Nat. Med."},{"key":"2026100909104760200_cit12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41420-024-01960-1","article-title":"Circadian Rhythm Regulates\nthe Function of Immune Cells and Participates in the Development of\nTumors","volume":"10","author":"Zeng","year":"2024","journal-title":"Cell Death Discovery"},{"key":"2026100909104760200_cit13","doi-asserted-by":"publisher","first-page":"1713801","DOI":"10.3389\/fonc.2025.1713801","article-title":"Relationship between Sleep Disorders\nand the Efficacy\nof Immune Checkpoint Inhibitors in Older Patients with Non-Small Cell\nLung Cancer","volume":"15","author":"Liu","year":"2026","journal-title":"Front. Oncol."},{"key":"2026100909104760200_cit14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory Markers\nin Depression:\nA Meta-Analysis of Mean Differences and Variability in 5,166 Patients\nand 5,083 Controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"2026100909104760200_cit15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6\nand Depression: A Systematic\nReview and Meta-Analysis of Longitudinal Studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J. Affect. Disord."},{"key":"2026100909104760200_cit16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000542676","article-title":"A Brief Historic Review of Research\non Early Life Stress and Inflammation\nacross the Lifespan","volume":"32","author":"Entringer","year":"2025","journal-title":"Neuroimmunomodulation"},{"key":"2026100909104760200_cit17","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1038\/npp.2017.137","article-title":"Evidence for Immune Activation and\nResistance to Glucocorticoids Following Childhood Maltreatment in\nAdolescents Without Psychopathology","volume":"42","author":"do Prado","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2026100909104760200_cit18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cobeha.2019.02.002","article-title":"Caregiving\nAlters Immunity and Stress Hormones: A Review\nof Recent Research","volume":"28","author":"Whittaker","year":"2019","journal-title":"Curr. Opin. Behav. Sci."},{"key":"2026100909104760200_cit19","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41380-018-0259-2","article-title":"Socioeconomic\nStatus and Inflammation:\nA Meta-Analysis","volume":"25","author":"Muscatell","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"2026100909104760200_cit20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbi.2019.01.018","article-title":"Childhood Socioeconomic\nStatus and Inflammation: A\nSystematic Review and Meta-Analysis","volume":"78","author":"Milaniak","year":"2019","journal-title":"Brain Behav.\nImmun."},{"key":"2026100909104760200_cit21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00262-020-02663-z","article-title":"Body Mass Index and Immune-Related\nAdverse Events in Patients on Immune Checkpoint Inhibitor Therapies:\nA Systematic Review and Meta-Analysis","volume":"70","author":"Guzman-Prado","year":"2021","journal-title":"Cancer\nImmunol. Immunother."},{"key":"2026100909104760200_cit22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180516","article-title":"Body Mass\nIndex and Adiposity Influence Responses to Immune Checkpoint Inhibition\nin Endometrial Cancer","volume":"134","author":"Gomez-Banoy","year":"2024","journal-title":"J. Clin. Invest."},{"key":"2026100909104760200_cit23","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/OTT.S156421","article-title":"Impact of\nSmoking on Efficacy of\nPD-1\/PD-L1 Inhibitors in Non-Small Cell Lung Cancer Patients: A Meta-Analysis","volume":"11","author":"Li","year":"2018","journal-title":"Onco Targets Ther."},{"key":"2026100909104760200_cit24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijid.2021.03.063","article-title":"Use of Antibiotics\nIs Associated with Worse Clinical Outcomes in Patients with Cancer\nTreated with Immune Checkpoint Inhibitors: A Systematic Review and\nMeta-Analysis","volume":"106","author":"Tsikala-Vafea","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"2026100909104760200_cit25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/curroncol31010017","article-title":"Impact of Opioid Use\non Duration of Therapy and Overall Survival for Patients with Advanced\nNon-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors","volume":"31","author":"Young","year":"2024","journal-title":"Curr. Oncol."},{"key":"2026100909104760200_cit26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/mco.2025.2848","article-title":"Research Progress on\nthe Impact of Opioids on the Tumor Immune Microenvironment","volume":"22","author":"Zhou","year":"2025","journal-title":"Mol. Clin. Oncol."},{"key":"2026100909104760200_cit27","article-title":"BEST (Biomarkers, EndpointS, and\nOther Tools) Resource","author":"FDA-NIH Biomarker Working Group.","year":"2021"},{"key":"2026100909104760200_cit28","article-title":"Enrichment Strategies for Clinical\nTrials to Support Determination of Effectiveness of Human Drugs and\nBiological Products: Guidance for Industry","author":"U.S. Food and Drug Administration.","year":"2019"},{"key":"2026100909104760200_cit29","volume-title":"ICH E9(R1)\nAddendum on Estimands and Sensitivity\nAnalysis in Clinical Trials","author":"International Council for Harmonisation.","year":"2019"}],"container-title":["ACS Pharmacology &amp; Translational\nScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.6c00432","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article-pdf\/9\/10\/2660\/68474013\/acsptsci.6c00432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article-pdf\/9\/10\/2660\/68474013\/acsptsci.6c00432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:31:36Z","timestamp":1791552696000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aptsfn\/article\/9\/10\/2660\/5427808\/Biography-as-Biology-in-Drug-Development-Bio"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,10]]},"published-print":{"date-parts":[[2026,10,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acsptsci.6c00432","relation":{},"ISSN":["2575-9108"],"issn-type":[{"value":"2575-9108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}